Other news to note for June 11, 2026
AI Briefing
- • Alnylam and Genmab form partnership to develop treatments for rare genetic disorders.
- • Cosylab partners with the University of California, San Diego for cancer research collaboration.
- • Sensorion partners with the French National Institute for Health and Medical Research for multiple sclerosis research.
Context
Several biopharma and med-tech companies are involved in recent happenings, including Alnylam and Cordex. Other companies mentioned include Cosylab, Excellthera, and Genesis.
These companies, along with Heron, Medexus, Predicta, Sensorion, Tenacia, and Verge, are part of deals and partnerships in the industry, with details available to paid subscribers.
Advertisement